340 related articles for article (PubMed ID: 27002756)
1. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2016 Mar; 16(4):537-43. PubMed ID: 27002756
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.
Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
Cancer Biomark; 2018 Feb; 21(3):505-511. PubMed ID: 29171983
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
[TBL] [Abstract][Full Text] [Related]
5. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.
Kaur S; Chakraborty S; Baine MJ; Mallya K; Smith LM; Sasson A; Brand R; Guha S; Jain M; Wittel U; Singh SK; Batra SK
PLoS One; 2013; 8(2):e55171. PubMed ID: 23383312
[TBL] [Abstract][Full Text] [Related]
6. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer.
Kuhlmann KF; van Till JW; Boermeester MA; de Reuver PR; Tzvetanova ID; Offerhaus GJ; Ten Kate FJ; Busch OR; van Gulik TM; Gouma DJ; Crawford HC
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):886-91. PubMed ID: 17507610
[TBL] [Abstract][Full Text] [Related]
8. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
Morris-Stiff G; Teli M; Jardine N; Puntis MC
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.
Kaur S; Baine MJ; Guha S; Ochi N; Chakraborty S; Mallya K; Thomas C; Crook J; Wallace MB; Woodward TA; Jain M; Singh S; Sasson AR; Skinner V; Raimondo M; Batra SK
Pancreas; 2013 Apr; 42(3):494-501. PubMed ID: 23146921
[TBL] [Abstract][Full Text] [Related]
10. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
[TBL] [Abstract][Full Text] [Related]
11. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Olakowski M; Lekstan A; Lampe P; Malecka-Panas E
Pancreatology; 2010; 10(6):689-94. PubMed ID: 21242708
[TBL] [Abstract][Full Text] [Related]
13. Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients.
El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
Scand J Clin Lab Invest; 2012 Dec; 72(8):602-7. PubMed ID: 23020231
[TBL] [Abstract][Full Text] [Related]
14. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis.
Satirapoj B; Kitiyakara C; Leelahavanichkul A; Avihingsanon Y; Supasyndh O
BMC Nephrol; 2017 Aug; 18(1):263. PubMed ID: 28778196
[TBL] [Abstract][Full Text] [Related]
15. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
[TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin as a marker for disease activity in lupus nephritis.
El Shahawy MS; Hemida MH; Abdel-Hafez HA; El-Baz TZ; Lotfy AM; Emran TM
Scand J Clin Lab Invest; 2018 Jul; 78(4):264-268. PubMed ID: 29533691
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic and Prognostic Significance of Serum Neutrophil Gelatinase-Associated Lipocalin Levels in Patients with Colorectal Cancer.
Ozemir IA; Aslan S; Eren T; Bayraktar B; Bilgic C; Isbilen B; Yalman H; Yigitbasi R; Alimoglu O;
Chirurgia (Bucur); 2016; 111(5):414-421. PubMed ID: 27819647
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
Pancreas; 2013 Jan; 42(1):149-54. PubMed ID: 22617715
[TBL] [Abstract][Full Text] [Related]
19. Urine Neutrophil Gelatinase-Associated Lipocalin a Possible Diagnostic Marker for Egyptian Hepatocellular Carcinoma Patients.
Abdelsameea E; Nada A; Omar N; Saleh SM; Naguib M; El-Ezawy HEM; Bakry L; Elsabaawy M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2259-2264. PubMed ID: 32856853
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of the detection of serum neutrophil gelatinase-associated lipocalin in human colorectal cancer].
Ding L; Zhang X; Zhang Y; Yang G; Liao X; Shen Z; Qiu J; Mao W; Hu L; Shao S; Shang S
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):589-93. PubMed ID: 24953369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
